I think the premarket traders were eager to buy a fresh biotech with good results
they bid it up
then those who follow it, realizing how far off the next set of results will be, and how much further off any FDA approval will be, decided to take profits
then there are those who short any huge pop in bios, also exerting downward pressure
just life in the biotech sector these day...rough stuff...